Last update 23 Jan 2025

Allogeneic T cell therapy(Smart Immune SAS)

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms-
Target-
Action-
Mechanism
T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaRefractory Acute Leukemia
Inactive Indication-
Originator Organization
Smart Immune SASSmart Immune SAS
Active Organization
Smart Immune SASSmart Immune SAS
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Allogeneic T cell therapy(Smart Immune SAS)
NCT04959903
/ RecruitingPhase 1/2
A Phase I/II Study Evaluating the Safety and the Efficacy of SMART101 Injection to Accelerate Immune Reconstitution After T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric and Adult Patients With Hematological Malignancies
100 Clinical Results associated with Allogeneic T cell therapy(Smart Immune SAS)
Login to view more data
100 Translational Medicine associated with Allogeneic T cell therapy(Smart Immune SAS)
Login to view more data
100 Patents (Medical) associated with Allogeneic T cell therapy(Smart Immune SAS)
Login to view more data
100 Deals associated with Allogeneic T cell therapy(Smart Immune SAS)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lymphoblastic LeukemiaPhase 2
United States
Smart Immune SASSmart Immune SAS
31 Dec 2021
Acute Myeloid LeukemiaPhase 2
United States
Smart Immune SASSmart Immune SAS
31 Dec 2021
Refractory Acute LeukemiaPhase 2
United States
Smart Immune SASSmart Immune SAS
31 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free